Anxiety and insomnia are common during pregnancy. For some mothers, sedatives are prescribed to help manage the symptoms. Now, a new study conducted by experts at Harvard Medical School offers some reassurance.
Researchers tracked around 4 million children born in South Korea between 2010 and 2022, comparing results based on whether they were exposed to benzodiazepines or Z-hypnotics in the womb. They looked at 12 neurodevelopmental conditions, including ADHD, autism, intellectual disability, and behavioral disorder.
Initially, exposed children appeared to have slightly higher rates of psychiatric conditions. But when experts compared siblings, accounting for shared genetics and setting, the difference disappeared. Some minimal increases were observed with early or late use of sleep medicines, and with longer use. These areas may require further investigation, researchers noted in their report published on April 29, 2026.
Take Control of Your Health Today
Quickly check your symptoms and understand your prescriptions with our smart, easy-to-use AI tools.
The overall study recommends that there is no substantial evidence that prenatal exposure to benzodiazepines or Z-hypnotics increases the risk of psychiatric disorders in children.
Some health experts, in this context, recommend using a symptom checker tool to identify key symptom changes after using the said medications.
For more interesting news and updates on pregnancy, stress management, insomnia, and the advantages of using a symptom checker, follow Medipedia. We help you stay up to date on the latest news and developments in health, medication, and treatment practices.
Disclaimer:
This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing any medication or treatment.